Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 150.71B | 151.16B | 149.17B | 142.65B | 134.09B | 146.73B |
Gross Profit | 32.33B | 33.30B | 29.54B | 31.55B | 26.18B | 26.80B |
EBITDA | 15.65B | 16.88B | 14.23B | 14.95B | 10.89B | 11.46B |
Net Income | 11.05B | 10.39B | 8.75B | 9.62B | 7.43B | 7.53B |
Balance Sheet | ||||||
Total Assets | 178.71B | 190.92B | 191.18B | 179.69B | 174.53B | 177.74B |
Cash, Cash Equivalents and Short-Term Investments | 39.87B | 39.43B | 45.34B | 65.24B | 42.98B | 44.42B |
Total Debt | 1.11B | 12.09B | 753.00M | 220.00M | 300.00M | 5.68B |
Total Liabilities | 68.92B | 81.35B | 80.18B | 78.52B | 80.18B | 87.19B |
Stockholders Equity | 109.04B | 108.73B | 110.34B | 100.60B | 93.91B | 90.14B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -6.37B | -17.73B | 26.28B | 7.43B | -4.03B |
Operating Cash Flow | 0.00 | -4.07B | -12.22B | 32.19B | 9.00B | -1.68B |
Investing Cash Flow | 0.00 | 1.26B | -8.44B | -5.60B | -2.39B | -2.05B |
Financing Cash Flow | 0.00 | 938.00M | -3.38B | -4.28B | -9.11B | 1.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥164.15B | 7.42 | 2.36% | 9.84% | 16.60% | ||
77 Outperform | ¥80.49B | 14.21 | 8.79% | 2.33% | 8.17% | -0.38% | |
76 Outperform | $640.23B | 31.53 | 6.03% | 1.61% | 6.25% | -30.48% | |
76 Outperform | ¥86.68B | 13.20 | 5.08% | 12.10% | 148.20% | ||
73 Outperform | ¥406.58B | 16.86 | 2.01% | 8.59% | 39.41% | ||
71 Outperform | $159.92B | 15.34 | 9.36% | 3.75% | 1.34% | 20.86% | |
71 Outperform | ¥252.71B | 13.12 | 8.49% | 3.08% | 6.31% | 13.02% |